Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BERGENBIO CONFIRMS FIRST PATIENT ENROLLED IN PHASE II TRIAL ASSESSING BEMCENTINIB AS A POTENTIAL TREATMENT FOR COVID-19 IN INDIA

Bergen, Norway – 24[th] November 2020: BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, today announces that the first patient in India has been enrolled in the company sponsored Phase II clinical trial (BGBC020), assessing the efficacy and safety of bemcentinib for the treatment of hospitalised COVID-19 patients. The Phase II study will recruit 120 hospitalised COVID-19 patients across seven sites in India and five in South Africa. 60 patients will receive bemcentinib (as monotherapy or

Instalco wins new assignment from Veidekke in Norway

The Instalco company, Romerike Elektro AS, has signed a new contract with Veidekke Entreprenør AS. The order value is SEK 42 million and it pertains to electrical installations at the new apartment complex, Løren Botaniske, in Oslo.Romerike Elektro and Veidekke have been collaborating for many years. The new project at Løren Botaniske is an extension of the Gartnerkvartalet project (also an apartment complex), where Elektro is doing the electrical installation work for Veidekke. “We are very proud that Veidekke has once again put its confidence in us. We are looking forward to working

The purity brought by Nocospray gives safety and peace of mind

It is of immeasurable value that people can be certain that spaces are completely clean and disinfected. Nocospray has been proven through research to be an effective disinfection method that is suitable for many applications.The effectiveness of eco-friendly Nocospray is based on hydrogen peroxide, which is dry-sprayed into the air and on surfaces of the area to be disinfected. Hydrogen peroxide breaks down into water and oxygen, leaving the surfaces dry and residue-free. The method is suitable for use in hospital wards, operating theatres, intensive care, ambulances, day-care centres and

NetEnt recreates a classic as it unveils Divine Fortune Megaways™

Megaways™ makeover adds an exciting new twist to one of NetEnt’s all-time favourite slots. NetEnt has produced an enhanced version of one of its most popular games Divine Fortune with the addition of the Megaways™ mechanic.  The game is the latest in NetEnt’s standard-setting back catalogue to be given the magic Megaways™ treatment after the recent successful launch of Twin Spin Megaways™. With an RTP of 96.09%, the 6-reel mythical-themed slot includes the same magical creatures and glittering coin symbols as the original, but this time is loaded with 117,649 Megaways™ and a

Black Friday and Cyber Monday in the troubling times of pandemic – Conotoxia experts advise

No busy shopping malls, no queues before opening a store, instead customers in front of a computer monitor or with a smartphone in hand, browsing through the websites of online merchants from around the world. This is how this year's sales festival may look like. Conotoxia analysts not only wonder if it is safer but also give some advice. Additionally, the fintech's customers can enjoy a promotional offer for Black Friday and Cyber Monday.Black Friday, the traditional sales and price cuts day, happens this year on November 27th. In turn, Cyber Monday, the response of the e-commerce industry

Scandion Oncology publishes prospectus relating to the rights issue and announces the intention of changing listing venue to Nasdaq First North Growth Market Sweden

The Board of Directors of Scandion Oncology A/S ("Scandion Oncology" or the “Company”) has prepared a prospectus (the “Prospectus”) relating to the issue of new shares with preferential rights for existing shareholders of approximately SEK 236 million (the “Rights Issue”), which was resolved on by the Board of Directors on 16 November 2020, pursuant to the authorization granted by the extraordinary general meeting held on 13 November 2020. The Prospectus has today been approved by and registered with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). Today, the Company also

Netmore builds nationwide LoRaWAN[®] networks for IoT – The project begins in Sweden

Netmore, the leading LoRaWAN operator in Sweden, is building their first nation wide IoT network to meet the need for increased digitalization within several industries. Together with Netmore’s current operator role in 70+ municipalities, the infrastructure rollout will create new conditions for all stakeholders who drive digitalization using IoT.LoRaWAN is a wireless data transmission technology which is characterized by energy efficiency and long range. It is purpose-built to create networks that provide connectivity for millions of connected sensors and actuators. On top of connectivity,

Aegirbio commences FDA fast track process with the Company's COVID-19 test

Aegirbio's U.S. team has reviewed the U.S. Food and Drug Administration's (FDA) requirements for marketing COVID-19 tests on the U.S. market. Building on the previous work undertaken to market the product in Europe, the Company is now ready to commence the FDA authorization process. Aegirbio's systematic effort to document the Company's COVID-19 tests for a launch in Europe under the CE-IVD Directive is thus expanded, as the request for Emergency Use Authorization (EUA) is submitted in the United States.The Company has further decided to invest in additional production capacity, expecting

Wärtsilä to provide technical and remote support for eight Teekay Shipping LNG Carriers

Wärtsilä Corporation, Trade press release, 24 November 2020 at 10:00 AM EETThe technology group Wärtsilä has signed LNG Support Agreements for eight LNG Carrier vessels owned by Teekay Gas, a part of the global Teekay Group. The two agreements, each for four vessels, were signed in August and September of this year. The agreements took effect from one month following their signing and are valid for 5 years. Wärtsilä has earlier supplied the LNG reliquefaction systems onboard all of the vessels covered by the agreements. Under the contract terms, Wärtsilä will provide both remote support,

Jetpak to offer Rail Courier- service in cooperation with VR - Finnish National Railways

VR begins to transport Jetpak shipments by rail. The Co-operation includes transportation of urgent shipments, such as sensitive samples and medicines from the healthcare sector as well as urgent industrial spare parts.  At this stage transports are possible to and from Helsinki. VR and Jetpak offer a wide range of domestic destinations from Helsinki with excellent frequency, up to one departure per hour and available 24/7. With rail connection customer receives door to door service at Jetpak speed! “We are excited about this collaboration and the new functionality which enables us

Aider partner with Findity to launch Aider Expense – a digital expense management solution

Aider is launching Aider Expense – a new expense management solution created to automate and simplify the expense process for their customers. The solution is built on Findity’s expense management platform and directly integrates with accounting and payroll systems like Visma and Xledger.“Expense management can be a hassle, and many of the solutions out there just don’t make it any smoother. With Aider Expense it really is a breeze.”Nina Abrahamsen, Partner at Aider Aider Expense is built to simplify the expense process for all users, and help reduce time spent on expense management for

Heliospectra AB (publ) announces the results of the rights issue

The subscription period for the rights issue in Heliospectra AB (publ) was completed on November 19, 2020 and the outcome of the rights issue shows that the rights issue was subscribed by approximately 124 percent. The rights issue, which was covered by subscription and guarantee commitments corresponding to 100 percent, was subscribed by approximately 91,6 percent with the support of unit rights and approximately 32,6 percent without the support of unit rights. The issue guarantee has therefore not been used. The rights issue provides the Company with approximately SEK 50,6 million, before

Qlife receives order for COVID-19 tests to European Women’s Handball Championship 2020

Qlife announces today that the company is entering into an agreement to deliver COVID-19 tests for the European Women’s Handball Championship 2020. The event will take place in Herning and Kolding, Denmark December 3-20. The testings will be performed daily, and the company expects approximately 5-6,000 tests during the tournament.”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high precision – as we know it from the healthcare system – and with answers

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 101 - 24 NOVEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Smoltek extends license agreement for evaluation of the company’s CNF-MIM-technology

Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has come to an agreement to extend the license agreement signed with a global manufacturer of electronic components for evaluation of Smoltek’s CNF-MIM technology. In addition to further evaluation, the parties will also discuss the way forward after the evaluation, including a potential broadening of the collaboration. This press release is an English version of the previously published Swedish version, which has interpretative preference.This spring, Smoltek announced two separate license agreements for technical and

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

Recipharm, a leading contract development and manufacturing organisation (CDMO) announces that it has signed a letter of intent with Moderna, a U.S. based biotech company, to formulate, fill and finish mRNA-1273, Moderna’s COVID-19 vaccine candidate. The activity will be performed in Recipharm’s drug product manufacturing facility located in Monts, France. Recipharm has reserved capacity to support the anticipated demand for the vaccine and is already in the process of recruiting additional staff and making certain investments to enable technology transfer and scale-up to commence

EG7 Broadcasts Presentation and Live Q&A

EG7 wants to inform its shareholders and other interested parties that a new video presentation will be uploaded on the company’s website at 9:00am CET on November 25, 2020. The purpose of the broadcast is to provide all shareholders with a presentation of the Q3 2020 interim report. EG7 will also broadcast a live Q&A where shareholders and other interested parties will be provided an opportunity to ask questions to the company at 9:30am CET on November 25, 2020. To access the video presentation, please use the following link at the given time: https://www.enadglobal7.com/financial-

Interim report January – September 2020

Press release: Uppsala, November 24, 2020. Pharmacolog i Uppsala AB’s (publ) interim report for the period January – September is now available on the company’s webbsite http://www.pharmacolog.com (Swedish only)Tredje kvartalet 1 juli 2020 – 30 september 2020 · Bolagets nettoomsättning för perioden uppgick till 16 (28) KSEK. · Rörelseresultatet för perioden uppgick till -2 042 (-3 155) KSEK. · Nettoresultat per aktie före och efter utspädning var för perioden -0,36 (-0,32) SEK. Perioden 1 januari 2020 – 30 september 2020 · Bolagets nettoomsättning för perioden uppgick

Spanish shipbuilder Gondan Shipyard orders PEMA VRWP-C robot welding solution

Gondan Shipyard is located in the Principality of Asturias. The shipyard has over 90-year-long experience in vessel manufacturing. Photo by Gondan Shipyard.   The Asturian ship manufacturer Gondan Shipyard has placed an order for a compact robot welding solution, PEMA VRWP-C. The shipyard, located in the North of Spain, has a long history in the industry as it has over 90-year-long experience in vessel manufacturing. Gondan is known for its accomplishments in shipbuilding, such as pioneering in manufacturing environmentally friendly vessels, but also vessels for very deep

Adverty is granted US patent for in-game ad viewability technology BrainImpression™

Adverty AB (publ) has been granted a patent by the United States Patent and Trademark Office for its in-game ad viewability technology BrainImpression™; a groundbreaking method for determining ad viewability and impressions within complex gaming environments. The patented invention is one of the core functionalities of Adverty’s leading in-game advertising platform.Adverty, the leading in-game platform for advertisers, agencies and game developers, today announces the notice of allowance for its in-game ad viewability technology patent by the United States Patent and Trademark Office. The

BillerudKorsnäs solution for E-Commerce mailers - the conscientious alternative for consumers and online retailers

E-Commerce mailer bags made from BillerudKorsnäs’ Xpression E-com paper have 50 percent lower fossil emissions than virgin plastic mailer bags and using this leads to the removal of biogenic carbon from the atmosphere. This is proven by a new independent study that compares the environmental impact of different types of e-commerce packaging. The global E-commerce market was already growing faster than other traditional channels prior to Covid-19, but the pandemic has boosted the move from brick and mortar stores to online purchasing. This transition is driving demand for packaging

Corruption remains a major problem in Asia, damaging trust in government, survey finds

Nearly one in five respondents paid a bribe while accessing essential services such as health careA report released today by Transparency International reveals that citizens across 17 countries in Asia report stagnant or rising levels of corruption, undermining equitable access to public services and trust in government.  Read the report  The report, Global Corruption Barometer – Asia, finds that three-quarters of respondents believe that government corruption is a big problem in their country, with nearly one in five people (19 per cent) paying

Everfuel – Company presentation

Herning, Denmark, 24 November 2020 – Everfuel A/S is presenting at the Fearnley Securities’ Annual Renewables Seminar today. Please see the attached presentation.   For additional information, please contact Jacob Krogsgaard, CEO, +45 2871 8945   About Everfuel | www.everfuel.comEverfuel is making green hydrogen for zero emission mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply- and fueling solutions. We own and operate green hydrogen infrastructure and partner with vehicle OEMs to connect the entire hydrogen value chain

InDex Pharmaceuticals presents at Redeye Life Science Day 2020

November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. The presentation will be livestreamed and can be followed at https://www.redeye.se/events/792760/redeye-life-science-day, where the presentation also will be available afterwards.The presentation will also be available afterwards on the company’s page in Redeye Universe (www.redeye.se/company/index-pharmaceuticals) and on the company’s website (www.indexpharma.com).   For more information: Peter Zerhouni,

There are no items matching the current filter
There are no more items matching the current filter
Back to top